EXPRESSF+ Trademark

Trademark Overview


On Monday, April 19, 1999, a trademark application was filed for EXPRESSF+ with the United States Patent and Trademark Office. The USPTO has given the EXPRESSF+ trademark a serial number of 75684834. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, December 16, 2021. This trademark is owned by PROTEIN SCIENCES CORPORATION. The EXPRESSF+ trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Cell lines for use in the production of recombinant proteins for medical and clinical use and cells for medical or clinical use, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent of Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are useful for the production and plaque-isolation...

Cell lines for use in the production of recombinant proteins for scientific, laboratory and medical research and cells for research of a scientific, laboratory or medical nature, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are...
expressf+

General Information


Serial Number75684834
Word MarkEXPRESSF+
Filing DateMonday, April 19, 1999
Status800 - REGISTERED AND RENEWED
Status DateThursday, December 16, 2021
Registration Number2359863
Registration DateTuesday, June 20, 2000
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 28, 2000

Trademark Statements


Goods and ServicesCell lines for use in the production of recombinant proteins for medical and clinical use and cells for medical or clinical use, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent of Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are useful for the production and plaque-isolation of genetically engineered baculovirus cells which meet the general identity and safety requirements for cells set by government regulatory agencies, and cells which are suitable for the manufacture of biological pharmaceutical products following cGMP standards
Goods and ServicesCell lines for use in the production of recombinant proteins for scientific, laboratory and medical research and cells for research of a scientific, laboratory or medical nature, including an insect line, a baculovirus-suspectible insect cell line, and a spodoptera frugiperda cell line having one or more of the following characteristics - cells which are genetically and morphologically distinct from the parent Sf9 cells, cells which replicate in serum-free medium, cells which grow as a suspension of single cells without significant clumping, cells which grow exponentially with a cell doubling time of 18 to 24 hours, cells which can be passed continuously for at least 6 months while maintaining a high level of viability (>98%), cells which are highly permissive to infection with californica npv baculoviruses resulting in high-titered virus stocks, cells which are useful for the production of recombinant DNA gene cell products following infection with baculovirus vectors, cells which are useful for the production and plaque-isolation of genetically engineered baculovirus cells which meet the general identity and safety requirements for cells set by government regulatory agencies, and cells which are suitable for the manufacture of biological pharmaceutical products following cGMP standards
Pseudo MarkEXPRESS F +; EXPRESS F PLUS

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, November 15, 1999
Primary Code001
First Use Anywhere DateWednesday, April 7, 1999
First Use In Commerce DateWednesday, April 7, 1999

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 1999
Primary Code005
First Use Anywhere DateWednesday, April 7, 1999
First Use In Commerce DateWednesday, April 7, 1999

Trademark Owner History


Party NamePROTEIN SCIENCES CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMeriden, CT 064507159

Party NamePROTEIN SCIENCES CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMeriden, CT 064507159

Party NamePROTEIN SCIENCES CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMeriden, CT 064507159

Trademark Events


Event DateEvent Description
Thursday, December 16, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, December 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 16, 2021REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, December 16, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, December 5, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 3, 2021PETITION TO DIRECTOR - GRANTED
Tuesday, November 30, 2021ASSIGNED TO PETITION STAFF
Wednesday, April 21, 2021TEAS PETITION TO DIRECTOR RECEIVED
Thursday, April 1, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Monday, January 25, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, October 15, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, September 30, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 20, 2020TEAS SECTION 8 & 9 RECEIVED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 19, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, January 4, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 4, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, October 11, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 21, 2010REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, May 21, 2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, May 18, 2010TEAS SECTION 8 & 9 RECEIVED
Thursday, March 1, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 20, 2007ASSIGNED TO PARALEGAL
Tuesday, December 19, 2006REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, December 19, 2006TEAS SECTION 8 & 15 RECEIVED
Thursday, March 23, 2006CASE FILE IN TICRS
Tuesday, June 20, 2000REGISTERED-PRINCIPAL REGISTER
Tuesday, March 28, 2000PUBLISHED FOR OPPOSITION
Friday, February 25, 2000NOTICE OF PUBLICATION
Friday, January 28, 2000APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 28, 2000USE AMENDMENT ACCEPTED
Monday, October 18, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 16, 1999NON-FINAL ACTION MAILED
Friday, September 3, 1999ASSIGNED TO EXAMINER
Friday, August 20, 1999ASSIGNED TO EXAMINER
Friday, July 30, 1999AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, June 30, 1999USE AMENDMENT FILED